Latest / The Dales Report | Trade to Black
MariMed Posts Strong Q2 2026 Results | Trade to Black
In the latest Trade To Black Podcast, host Shadd Dales sits down with MariMed (OTCQX: MRMD) CEO Jon Levine and Chief Commercial Officer Ryan Crandall to walk through the company’s Q2 2026 performance and the momentum building across U.S. cannabis.MariMed reported $41.9 million in Q2 2026 revenue, up 6% year‑over‑year, along with positive cash flow and 26 consecutive quarters of positive adjusted EBITDA. As Jon explains, “We built out every one of our facilities and kitchens with GMP to make sure that we’re compliant with the future for the Food and Drug Administration.”The episode highlights…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.